🚀 VC round data is live in beta, check it out!

Dr.Finance Valuation Multiples

Discover revenue and EBITDA valuation multiples for Dr.Finance and similar public comparables like Ditix, Wierzyciel, One Solution, LexBono and more.

Dr.Finance Overview

About Dr.Finance

Dr.Finance SA is a financial intermediary in the sale of loans and other financial products. It operates in the business of Working capital loans, Investment loans, Leasing, and Factoring.


Founded

2008

HQ

Poland

Employees

2

Financials (FY)

Revenue: $3M
EBITDA: ($50K)

EV

$1M

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Dr.Finance Financials

Dr.Finance reported last fiscal year revenue of $3M and negative EBITDA of ($50K).

In the same fiscal year, Dr.Finance generated $3M in gross profit, ($50K) in EBITDA losses, and had net loss of ($66K).


Dr.Finance P&L

In the most recent fiscal year, Dr.Finance reported revenue of $3M and EBITDA of ($50K).

Dr.Finance expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Dr.Finance forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
RevenueXXX$3MXXXXXXXXX
Gross ProfitXXX$3MXXXXXXXXX
Gross MarginXXX96%XXXXXXXXX
EBITDAXXX($50K)XXXXXXXXX
EBITDA MarginXXX(2%)XXXXXXXXX
EBIT MarginXXX(2%)XXXXXXXXX
Net ProfitXXX($66K)XXXXXXXXX
Net MarginXXX(2%)XXXXXXXXX

Financial data powered by Morningstar, Inc.

Dr.Finance Stock Performance

Dr.Finance has current market cap of $1M, and enterprise value of $1M.

Market Cap Evolution


Dr.Finance's stock price is $0.33.

See Dr.Finance trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1M$1M(0.5%)XXXXXXXXX$-0.02

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Dr.Finance Valuation Multiples

Dr.Finance trades at 0.4x EV/Revenue multiple, and (23.4x) EV/EBITDA.

See valuation multiples for Dr.Finance and 15K+ public comps

Dr.Finance Financial Valuation Multiples

As of March 7, 2026, Dr.Finance has market cap of $1M and EV of $1M.

Equity research analysts estimate Dr.Finance's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Dr.Finance has a P/E ratio of (18.4x).

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$1MXXX$1MXXXXXXXXX
EV (current)$1MXXX$1MXXXXXXXXX
EV/RevenueXXX0.4xXXXXXXXXX
EV/EBITDAXXX(23.4x)XXXXXXXXX
EV/EBITXXX(23.1x)XXXXXXXXX
EV/Gross ProfitXXX0.4xXXXXXXXXX
P/EXXX(18.4x)XXXXXXXXX
EV/FCFXXX49.2xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Dr.Finance Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Dr.Finance Margins & Growth Rates

Dr.Finance's revenue in the last fiscal year grew by 65%.

See operational valuation multiples for Dr.Finance and other 15K+ public comps

Dr.Finance Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue GrowthXXX65%XXXXXXXXX
EBITDA MarginXXX(2%)XXXXXXXXX
EBITDA GrowthXXX344%XXXXXXXXX
Opex to RevenueXXX98%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Dr.Finance Public Comps

See public comps and valuation multiples for other Specialty Finance comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
DitixXXXXXXXXXXXXXXXXXX
WierzycielXXXXXXXXXXXXXXXXXX
One SolutionXXXXXXXXXXXXXXXXXX
LexBonoXXXXXXXXXXXXXXXXXX
Ventana GlobalXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Dr.Finance M&A Activity

Dr.Finance acquired XXX companies to date.

Last acquisition by Dr.Finance was on XXXXXXXX, XXXXX. Dr.Finance acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Dr.Finance

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Dr.Finance Investment Activity

Dr.Finance invested in XXX companies to date.

Dr.Finance made its latest investment on XXXXXXXX, XXXXX. Dr.Finance invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Dr.Finance

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Dr.Finance

When was Dr.Finance founded?Dr.Finance was founded in 2008.
Where is Dr.Finance headquartered?Dr.Finance is headquartered in Poland.
How many employees does Dr.Finance have?As of today, Dr.Finance has over 2 employees.
Is Dr.Finance publicly listed?Yes, Dr.Finance is a public company listed on Warsaw Stock Exchange.
What is the stock symbol of Dr.Finance?Dr.Finance trades under DRF ticker.
When did Dr.Finance go public?Dr.Finance went public in 2008.
Who are competitors of Dr.Finance?Dr.Finance main competitors are Ditix, Wierzyciel, One Solution, LexBono.
What is the current market cap of Dr.Finance?Dr.Finance's current market cap is $1M.
What is the current revenue of Dr.Finance?Dr.Finance's last fiscal year revenue is $3M.
What is the current EV/Revenue multiple of Dr.Finance?Current revenue multiple of Dr.Finance is 0.4x.
Is Dr.Finance profitable?No, Dr.Finance is not profitable.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial